logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Eric P. Winer

yale university
H指数:170
被引数:12.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer

年轻早期乳腺癌女性患者的妊娠史、分娩近期性及预后结局

JNCI: Journal of the National Cancer Institute
IF0
2026-05-180
PRE
Guilherme Nader-Marta, MD; Yue Zheng, MS; Shoshana M Rosenberg, Scd, MPH; Kate E Dibble, Phd; Erica L Mayer, MD, MPH; Philip D Poorvu, MD; Kathryn J Ruddy, MD, MPH; Yaileen D Guzman-Arocho, MD; Laura C Collins, MD; Jeffrey Peppercorn, MD, MPH; Lidia Schapira, MD; Carmine Valenza, MD, MPH; Virginia F Borges, MD, Mmsc; Nabihah Tayob, Phd; Steven E Come, MD; Ellen Warner, MD, Msc; Kornelia Polyak, MD, Phd; Eric P Winer, MD; Ann H Partridge, MD MPH
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer

曲妥珠单抗德鲁克替康在晚期乳腺癌中的分子与临床疗效洞察

JNCI: Journal of the National Cancer Institute
IF0
2025-12-040
PRE
Amin H Nassar; Elias Bou Farhat; Hassan Abushukair; Michel Alchoueriy; Samer Salem; Marc Machaalani; Elio Adib; Elizabeth P Henske; Priyanka Babu; Toni K Choueiri; Mehrdad Rakaee; Lill-Tove Rasmussen Busund; Yamato Takabe; Shun-Fat Lau; Kerri Rall; Abdul Rafeh Naqash; Caroline Jansen; Xiao Wang; Pavan Challa; Paolo Tarantino; Ann H Partridge; Sara M Tolaney; David J Kwiatkowski; Eric P Winer
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

帕博西利联合辅助内分泌疗法在早期乳腺癌中的应用：全球多中心、开放标签、随机III期PALLAS试验（ABCSG-42/AFT-05/PrE0109/BIG-14-13）五年随访分析

Annals of Oncology
IF65.4
2025-10-170
OAAI
E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy

潜在生物标志物与接受帕博利珠单抗或化疗治疗的转移性三阴性乳腺癌患者临床结局的关联

npj Breast Cancer
IF7.6
2025-10-020
OA
Javier Cortes; Oleg Lipatov; Seock-Ah Im; Anthony Goncalves; Keun Seok Lee; Peter Schmid; Kenji Tamura; Laura Testa; Shoichiro Ohtani; Nadia Harbeck; Sherene Loi; Roberto Salgado; Vassiliki Karantza; Jaime Mejia; Razvan Cristescu; Andrey Loboda; Michael Nebozhyn; Petar Jelinic; Lingkang Huang; Eric P. Winer
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA

检测细胞游离DNA中酪氨酸激酶抑制剂异质性耐药机制

Cell Genomics
IF9
2025-09-090
OAAI
Heather A. Parsons; Conor Messer; Katheryn Santos; Jakob Weiss; David Merrell; Brian P. Danysh; Melissa E. Hughes; Gregory J. Kirkner; Ashka Patel; Julian Hess; Kerry Sendrick; Chip Stewart; Elizabeth Grant; Kristy Schlueter-Kuck; Albert Grinshpun; Nikhil Wagle; Jamunarani Veeraraghavan; Jose Pablo Leone; Rachel A. Freedman; Otto Metzger; Rachel Schiff; Eric P. Winer; Sara M. Tolaney; Mothaffar Rimawi; Ian E. Krop; Gad Getz; Nancy U. Lin
Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients

预测年轻乳腺癌患者接受化疗和抗HER2治疗后卵巢功能丧失

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-013
OAAI
Lambertini, Matteo; Allegranza, Deirdre; Laubender, Ruediger P.; Harbeck, Nadia; Swain, Sandra M.; Geyer, Charles E.; Slamon, Dennis J.; Bobba, Gabriella; Lambertini, Chiara; de Haas, Sanne; Restuccia, Eleonora; Vaz-Luis, Ines; Cameron, David A.; Krop, Ian E.; Winer, Eric P.; Anderson, Richard A.
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

曲妥珠单抗德鲁替康后转移性乳腺癌患者的后续治疗方案结果

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-012
PRE
Tarantino, Paolo; Lee, Do; Foldi, Julia; Soulos, Pamela R.; Gross, Cary P.; O'Meara, Tess; Grinda, Thomas; Morganti, Stefania; Waks, Adrienne G.; Winer, Eric P.; Lin, Nancy U.; Krop, Ian E.; Tolaney, Sara M.; Sammons, Sarah; Lustberg, Maryam
Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer

曲妥珠单抗德鲁替康（trastuzumab deruxtecan）在不同生物标志物状态、治疗线数以及之前是否接受过沙西妥珠单抗戈维替康（sacituzumab govitecan）治疗的患者中的疗效，基于一项大型真实世界数据库的转移性乳腺癌患者研究。

ESMO Open
IF8.3
2025-07-010
PRE
P. Tarantino; D. Lee; J. Foldi; P.R. Soulos; C.P. Gross; T. Grinda; E.P. Winer; N.U. Lin; I.E. Krop; S.M. Tolaney; M. Lustberg; S. Sammons
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
BREAST
IF7.9
2025-06-010
OAAI
Hennessy, Maeve A.; Cimino-Mathews, Ashley; Carter, Jodi M.; Kachergus, Jennifer M.; Ma, Yaohua; Leal, Jeffrey P.; Solnes, Lilja B.; Abramson, Vandana G.; Carey, Lisa A.; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C.; Wahl, Richard L.; Huang, Chiung-Yu; Stearns, Vered; Thompson, E. Aubrey; Connolly, Roisin M.
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
BREAST CANCER RESEARCH
IF5.6
2025-01-230
OAAI
Demichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H.; Pfeiler, G.; Zdenkowski, N.; Wolff, A.; Bellet-Ezquerra, M.; Winer, E.; Balic, M.; Miller, K.; Colleoni, M.; Lake, D.; Rubovsky, G.; Cameron, D.; Balko, J.; Singer, C. F.; Nowecki, Z.; Iwata, H.; Wolmark, N.; Parraga, K. A.; Rugo, H.; Steger, G. G.; Traina, T.; Werutsky, G.; Czajkowska, D.; Metzger, O.; El-Abed, S.; Theall, K. P.; Lu, R. D.; O'Brien, P.; Fesl, C.; Mayer, E.; Gnant, M.
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

跨临床病理特征的转移性乳腺癌活检的多模态单细胞和空间表达图

NATURE MEDICINE
IF50
2024-10-301
OAAI
Klughammer, Johanna; Abravanel, Daniel L.; Segerstolpe, Asa; Blosser, Timothy R.; Goltsev, Yury; Cui, Yi; Goodwin, Daniel R.; Sinha, Anubhav; Ashenberg, Orr; Slyper, Michal; Vigneau, Sebastien; Jane-Valbuena, Judit; Alon, Shahar; Caraccio, Chiara; Chen, Judy; Cohen, Ofir; Cullen, Nicole; DelloStritto, Laura K.; Dionne, Danielle; Files, Janet; Frangieh, Allison; Helvie, Karla; Hughes, Melissa E.; Inga, Stephanie; Kanodia, Abhay; Lako, Ana; MacKichan, Colin; Mages, Simon; Moriel, Noa; Murray, Evan; Napolitano, Sara; Nguyen, Kyleen; Nitzan, Mor; Ortiz, Rebecca; Patel, Miraj; Pfaff, Kathleen L.; Porter, Caroline B. M.; Rotem, Asaf; Strauss, Sarah; Strasser, Robert; Thorner, Aaron R.; Turner, Madison; Wakiro, Isaac; Waldman, Julia; Wu, Jingyi; Zanudo, Jorge Gomez Tejeda; Zhang, Diane; Lin, Nancy U.; Tolaney, Sara M.; Winer, Eric P.; Boyden, Edward S.; Chen, Fei; Nolan, Garry P.; Rodig, Scott J.; Zhuang, Xiaowei; Rozenblatt-Rosen, Orit; Johnson, Bruce E.; Regev, Aviv; Wagle, Nikhil
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing

适应社会生态模型以解决黑人参与前列腺癌基因检测的差异

BMC PUBLIC HEALTH
IF3.6
2024-09-180
OAAI
Leader, Amy E.; Rebbeck, Timothy R.; Oh, William K.; Patel, Alpa V.; Winer, Eric P.; Bailey, LeeAnn O.; Gomella, Leonard G.; Lumpkins, Crystal Y.; Garraway, Isla P.; Aiello, Lisa B.; Baskin, Monica L.; Cheng, Heather H.; Cooney, Kathleen A.; Ganzak, Amanda; George, Daniel J.; Halabi, Susan; Hathaway, Feighanne; Healy, Claire; Kim, Joseph W.; Leapman, Michael S.; Loeb, Stacy; Maxwell, Kara N.; McNair, Christopher; Morgan, Todd M.; Prindeville, Breanne; Soule, Howard R.; Steward, Whitney L.; Suttiratana, Sakinah C.; Taplin, Mary-Ellen; Yamoah, Kosj; Fortune, Thierry; Bennett, Kris; Blanding-Godbolt, Joshua; Gross, Laura; Giri, Veda N.
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival

乳腺原发灶到脑转移灶HER2表达变化分析HER2-low表达对总生存期的影响

NEURO-ONCOLOGY
IF13.4
2024-08-301
OAAI
Pereslete, Alyssa M.; Hughes, Melissa E.; Martin, Alyssa R.; Files, Janet; Nguyen, Kyleen; Buckley, Lauren; Patel, Ashka; Moore, Abigail; Winer, Eric P.; Dillon, Deborah; Li, Tianyu; Tolaney, Sara M.; Lin, Nancy U.; Sammons, Sarah L.

研究方向

暂未获取到该数据
N
Nancy U. Lin
H 指数:95论文数:1,073被引数:4.1万
I
Ian E. Krop
H 指数:99论文数:859被引数:4.1万
S
Sara M. Tolaney
H 指数:83论文数:1,340被引数:3.5万
A
Ann H. Partridge
H 指数:100论文数:1,042被引数:4.5万
H
Harold J. Burstein
H 指数:102论文数:446被引数:5.2万
C
Clifford A. Hudis
H 指数:126论文数:938被引数:8.1万
W
William T. Barry
H 指数:62论文数:487被引数:1.5万
L
Lisa A. Carey
H 指数:104论文数:988被引数:5.3万
H
Hope S. Rugo
H 指数:137论文数:1,616被引数:10.0万
R
Rachel A. Freedman
H 指数:41论文数:355被引数:7,426